Trintellix (Takeda Pharmaceuticals America, Inc.)


Welcome to the PulseAid listing for the Trintellix drug offered from Takeda Pharmaceuticals America, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Takeda Pharmaceuticals America, Inc.
NON-PROPRIETARY NAME: vortioxetine
SUBSTANCE NAME: VORTIOXETINE HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-10-02
END MARKETING DATE: 0000-00-00


Trintellix HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrintellix from Takeda Pharmaceuticals America, Inc.
LABELER NAME: Takeda Pharmaceuticals America, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2013-10-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64764-720_fc117e75-5c73-4373-ad38-76b73bfc6073
PRODUCT NDC: 64764-720
APPLICATION NUMBER: NDA204447

Other VORTIOXETINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalBrintellix
Takeda Pharmaceuticals America, Inc.Brintellix